CGS-authored

Critics say board isn't as public as it ought to be California's big stem cell enterprise is up and running, but critics claim it's headed the wrong way.

After canceling most of its first meeting because of legal concerns, the board created to direct the voter-approved Proposition 71 stem cell program is trying again with a second meeting Thursday. And once more, complaints are being heard about inattention to some of the peskier details involved in conducting public business.

The second meeting of the state Independent Citizens Oversight Committee is "problematic" in the view of at least one critic of the $3 billion stem cell enterprise.

The 29-member committee was created in November by state voters as part of Proposition 71. The committee's job is to direct activities of a new "California Institute for Regenerative Medicine," which is supposed to distribute $3 billion of taxpayer-backed bonds for research and facilities during the next decade. Already, open-government advocates charge that the new state-sponsored institute isn't trying hard enough to conduct its affairs in public.

The committee's first meeting on Dec. 17...